OPT SpA (MIL:OPTS) Research & Development: € Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:OPTS OPT SpA MIL:OPTS
10 GF Score
Price €0.76
! 1 Warning Sign
View Full Analysis

What is OPT SpA Research & Development?

OPT SpA MIL:OPTS +5.56% 10 Research & Development is € Mil as of Dec. 2025. GuruFocus rates MIL:OPTS with a GF Score™ of 10/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. OPT SpA's Research & Development for the six months ended in Dec. 2025 was €0.02 Mil. OPT SpA does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in Dec. 2025.

OPT SpA  (MIL:OPTS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

OPT SpA Research & Development Related Terms

OPT SpA Research & Development Historical Data

* Premium members only.

The historical data trend for OPT SpA's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OPT SpA Research & Development Chart

OPT SpA Annual Data
Trend Dec24 Dec25
Research & Development
0.02 0.02

OPT SpA Semi-Annual Data
Dec24 Dec25
Research & Development 0.02 0.02
MIL:OPTS
10GF Score
OPT SpA MIL:OPTS
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OPT SpA Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of € Mil mean?
OPT SpA (MIL:OPTS) has a Research & Development of € Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on OPT SpA and its competitors.
Is OPT SpA's Research & Development too high?
OPT SpA's current Research & Development is € Mil. Overall, OPT SpA has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does OPT SpA's Research & Development compare to VRSK and EFX?
OPT SpA's Research & Development of € Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Business Services company?
A good Research & Development depends on the Business Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on OPT SpA and its competitors. OPT SpA's current Research & Development is € Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OPT SpA stock overvalued right now?
OPT SpA (MIL:OPTS) has a current Research & Development of € Mil. The current Research & Development is € Mil. OPT SpA's overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For OPT SpA (MIL:OPTS), the current Research & Development is € Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OPT SpA Business Description

Address Via Mauro Macchi 38, Milan, ITA, 20124
OPT SpA operates in the healthcare high value-added services (HHVAS) sector, providing clinical and organizational solutions for public and private healthcare facilities. Its services include the development and implementation of operational solutions, combining clinical, organizational, scientific, and digital expertise to support healthcare organizations. The company provides specialized healthcare services related to therapy adoption, healthcare process organization, and care pathway management.
10GF Score

Get the complete analysis for MIL:OPTS

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.76
Price